nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—MPO—saliva—nicotine dependence	0.101	0.326	CbGeAlD
Cysteamine—NPY2R—brain—nicotine dependence	0.0634	0.205	CbGeAlD
Cysteamine—SST—cardiovascular system—nicotine dependence	0.0504	0.163	CbGeAlD
Cysteamine—SST—midbrain—nicotine dependence	0.0394	0.127	CbGeAlD
Cysteamine—NPY2R—Peptide GPCRs—OPRM1—nicotine dependence	0.0276	0.0612	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0271	0.0601	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.026	0.0576	CbGpPWpGaD
Cysteamine—SST—brain—nicotine dependence	0.0247	0.0801	CbGeAlD
Cysteamine—SST—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.0233	0.0515	CbGpPWpGaD
Cysteamine—MPO—cardiovascular system—nicotine dependence	0.0203	0.0657	CbGeAlD
Cysteamine—SST—GPCR ligand binding—TAS2R16—nicotine dependence	0.0164	0.0364	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—TAS2R16—nicotine dependence	0.0158	0.0349	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.0155	0.0344	CbGpPWpGaD
Cysteamine—Scotoma—Varenicline—nicotine dependence	0.0152	0.0634	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.0141	0.0312	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.0136	0.03	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.013	0.0288	CbGpPWpGaD
Cysteamine—Thinking abnormal—Varenicline—nicotine dependence	0.0126	0.0526	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—CHRNB2—nicotine dependence	0.0122	0.0269	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—OPRM1—nicotine dependence	0.0114	0.0253	CbGpPWpGaD
Cysteamine—Nightmare—Varenicline—nicotine dependence	0.0111	0.0465	CcSEcCtD
Cysteamine—NPY2R—G alpha (i) signalling events—OPRM1—nicotine dependence	0.011	0.0243	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0102	0.0225	CbGpPWpGaD
Cysteamine—Mental disability—Varenicline—nicotine dependence	0.01	0.0418	CcSEcCtD
Cysteamine—MPO—brain—nicotine dependence	0.00996	0.0323	CbGeAlD
Cysteamine—SST—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00929	0.0206	CbGpPWpGaD
Cysteamine—Eye pain—Varenicline—nicotine dependence	0.00928	0.0387	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0091	0.0201	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—DRD2—nicotine dependence	0.00899	0.0199	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0089	0.0197	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00872	0.0193	CbGpPWpGaD
Cysteamine—Lethargy—Varenicline—nicotine dependence	0.00855	0.0357	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—TAS2R16—nicotine dependence	0.00843	0.0187	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—DRD2—nicotine dependence	0.00827	0.0183	CbGpPWpGaD
Cysteamine—Affect lability—Varenicline—nicotine dependence	0.00825	0.0344	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—TAS2R16—nicotine dependence	0.00808	0.0179	CbGpPWpGaD
Cysteamine—Mood swings—Varenicline—nicotine dependence	0.00794	0.0331	CcSEcCtD
Cysteamine—NPY2R—G alpha (i) signalling events—DRD2—nicotine dependence	0.00793	0.0176	CbGpPWpGaD
Cysteamine—Liver function test abnormal—Varenicline—nicotine dependence	0.00774	0.0323	CcSEcCtD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00736	0.0163	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—FGD1—nicotine dependence	0.00729	0.0161	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—FGD1—nicotine dependence	0.00699	0.0155	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—OPRM1—nicotine dependence	0.00693	0.0153	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—OPRM1—nicotine dependence	0.00664	0.0147	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—FGD1—nicotine dependence	0.00662	0.0147	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00658	0.0146	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—FGD1—nicotine dependence	0.00634	0.014	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0063	0.014	CbGpPWpGaD
Cysteamine—Hallucination—Varenicline—nicotine dependence	0.00577	0.0241	CcSEcCtD
Cysteamine—Urinary tract disorder—Varenicline—nicotine dependence	0.00572	0.0239	CcSEcCtD
Cysteamine—Connective tissue disorder—Varenicline—nicotine dependence	0.0057	0.0238	CcSEcCtD
Cysteamine—Urethral disorder—Varenicline—nicotine dependence	0.00568	0.0237	CcSEcCtD
Cysteamine—Immune system disorder—Varenicline—nicotine dependence	0.00524	0.0219	CcSEcCtD
Cysteamine—Mental disorder—Varenicline—nicotine dependence	0.00508	0.0212	CcSEcCtD
Cysteamine—Erythema—Varenicline—nicotine dependence	0.00505	0.0211	CcSEcCtD
Cysteamine—Malnutrition—Varenicline—nicotine dependence	0.00505	0.0211	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—DRD2—nicotine dependence	0.00501	0.0111	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TAS2R16—nicotine dependence	0.00498	0.011	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—DRD2—nicotine dependence	0.0048	0.0106	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TAS2R16—nicotine dependence	0.00478	0.0106	CbGpPWpGaD
Cysteamine—Tremor—Varenicline—nicotine dependence	0.00473	0.0197	CcSEcCtD
Cysteamine—Anaemia—Varenicline—nicotine dependence	0.00466	0.0195	CcSEcCtD
Cysteamine—Agitation—Varenicline—nicotine dependence	0.00464	0.0194	CcSEcCtD
Cysteamine—Convulsion—Varenicline—nicotine dependence	0.00437	0.0182	CcSEcCtD
Cysteamine—Hypertension—Varenicline—nicotine dependence	0.00436	0.0182	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00427	0.0178	CcSEcCtD
Cysteamine—Discomfort—Varenicline—nicotine dependence	0.00424	0.0177	CcSEcCtD
Cysteamine—Nervous system disorder—Varenicline—nicotine dependence	0.00404	0.0169	CcSEcCtD
Cysteamine—Skin disorder—Varenicline—nicotine dependence	0.004	0.0167	CcSEcCtD
Cysteamine—Anorexia—Varenicline—nicotine dependence	0.00393	0.0164	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—OPRM1—nicotine dependence	0.00391	0.00867	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FGD1—nicotine dependence	0.00391	0.00866	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—OPRM1—nicotine dependence	0.00375	0.00831	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGD1—nicotine dependence	0.00375	0.0083	CbGpPWpGaD
Cysteamine—Somnolence—Varenicline—nicotine dependence	0.00366	0.0153	CcSEcCtD
Cysteamine—Dyspepsia—Varenicline—nicotine dependence	0.00363	0.0151	CcSEcCtD
Cysteamine—Decreased appetite—Varenicline—nicotine dependence	0.00358	0.0149	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00356	0.0148	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—OPRM1—nicotine dependence	0.00355	0.00787	CbGpPWpGaD
Cysteamine—Fatigue—Varenicline—nicotine dependence	0.00355	0.0148	CcSEcCtD
Cysteamine—Constipation—Varenicline—nicotine dependence	0.00352	0.0147	CcSEcCtD
Cysteamine—SST—Signaling Pathways—AKR1B10—nicotine dependence	0.00345	0.00765	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—OPRM1—nicotine dependence	0.00341	0.00755	CbGpPWpGaD
Cysteamine—Feeling abnormal—Varenicline—nicotine dependence	0.00339	0.0142	CcSEcCtD
Cysteamine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00337	0.0141	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—AKR1B10—nicotine dependence	0.00331	0.00733	CbGpPWpGaD
Cysteamine—Urticaria—Varenicline—nicotine dependence	0.00327	0.0137	CcSEcCtD
Cysteamine—Body temperature increased—Varenicline—nicotine dependence	0.00326	0.0136	CcSEcCtD
Cysteamine—Abdominal pain—Varenicline—nicotine dependence	0.00326	0.0136	CcSEcCtD
Cysteamine—Hypersensitivity—Varenicline—nicotine dependence	0.00303	0.0127	CcSEcCtD
Cysteamine—Asthenia—Varenicline—nicotine dependence	0.00295	0.0123	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—DRD2—nicotine dependence	0.00283	0.00627	CbGpPWpGaD
Cysteamine—Diarrhoea—Varenicline—nicotine dependence	0.00282	0.0118	CcSEcCtD
Cysteamine—Dizziness—Varenicline—nicotine dependence	0.00272	0.0114	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—DRD2—nicotine dependence	0.00271	0.00601	CbGpPWpGaD
Cysteamine—Vomiting—Varenicline—nicotine dependence	0.00262	0.0109	CcSEcCtD
Cysteamine—Rash—Varenicline—nicotine dependence	0.0026	0.0108	CcSEcCtD
Cysteamine—Dermatitis—Varenicline—nicotine dependence	0.00259	0.0108	CcSEcCtD
Cysteamine—Headache—Varenicline—nicotine dependence	0.00258	0.0108	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—DRD2—nicotine dependence	0.00257	0.00569	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—DRD2—nicotine dependence	0.00246	0.00546	CbGpPWpGaD
Cysteamine—Nausea—Varenicline—nicotine dependence	0.00245	0.0102	CcSEcCtD
Cysteamine—SST—Signaling Pathways—WASF2—nicotine dependence	0.00243	0.00539	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—WASF1—nicotine dependence	0.00233	0.00517	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—WASF2—nicotine dependence	0.00233	0.00517	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—WASF1—nicotine dependence	0.00224	0.00495	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—OPRM1—nicotine dependence	0.0021	0.00465	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—OPRM1—nicotine dependence	0.00201	0.00446	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—DRD2—nicotine dependence	0.00152	0.00336	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—DRD2—nicotine dependence	0.00146	0.00322	CbGpPWpGaD
